Adoptive immunotherapy for Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease
The aim of this study was to establish a pre-clinical SCID mouse model of PTLD in which to test CTL immunotherapy. EBV <i>in vitro</i> infected B lymphoblastoid cell lines (BLCLs) were used to give rise to PTLD-like lesions in SCID mice. A minimum dose of 2x10<sup>6</sup> BLC...
| Main Author: | |
|---|---|
| Published: |
University of Edinburgh
2007
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.653019 |